Published in Am J Pathol on November 01, 2005
Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol (2009) 7.34
Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol (2010) 2.55
Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J Clin Invest (2011) 2.43
Mechanisms of disease: epithelial-mesenchymal transition--does cellular plasticity fuel neoplastic progression? Nat Clin Pract Oncol (2008) 2.18
Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney Int (2011) 2.15
Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol (2010) 1.93
Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Diabetes (2009) 1.87
NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts. J Am Soc Nephrol (2009) 1.80
Origin of renal myofibroblasts in the model of unilateral ureter obstruction in the rat. Histochem Cell Biol (2008) 1.77
Fibroblasts and myofibroblasts in renal fibrosis. Int J Exp Pathol (2011) 1.76
Fibroblast activation and myofibroblast generation in obstructive nephropathy. Nat Rev Nephrol (2009) 1.76
AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes. J Biol Chem (2010) 1.60
The origin of interstitial myofibroblasts in chronic kidney disease. Pediatr Nephrol (2011) 1.55
Autophagy is a component of epithelial cell fate in obstructive uropathy. Am J Pathol (2010) 1.53
The role played by perivascular cells in kidney interstitial injury. Clin Nephrol (2012) 1.49
Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels. Proc Natl Acad Sci U S A (2009) 1.44
Regulation of elongation phase of mRNA translation in diabetic nephropathy: amelioration by rapamycin. Am J Pathol (2007) 1.41
Transforming growth factor β-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis. Am J Pathol (2012) 1.38
Polymorphisms in the 3' UTR in the neurocalcin delta gene affect mRNA stability, and confer susceptibility to diabetic nephropathy. Hum Genet (2007) 1.25
Epithelial to mesenchymal transition as a biomarker in renal fibrosis: are we ready for the bedside? Fibrogenesis Tissue Repair (2011) 1.12
Dual-immunohistochemistry provides little evidence for epithelial-mesenchymal transition in pulmonary fibrosis. Histochem Cell Biol (2008) 1.10
The role of cell plasticity in progression and reversal of renal fibrosis. Int J Exp Pathol (2011) 1.08
Mammalian target of rapamycin regulates Nox4-mediated podocyte depletion in diabetic renal injury. Diabetes (2013) 1.08
The origin of renal fibroblasts and progression of kidney disease. Am J Pathol (2009) 1.05
RhoA/Rho kinase mediates TGF-β1-induced kidney myofibroblast activation through Poldip2/Nox4-derived reactive oxygen species. Am J Physiol Renal Physiol (2014) 1.02
Cholangiocytes with mesenchymal features contribute to progressive hepatic fibrosis of the polycystic kidney rat. Am J Pathol (2007) 0.98
Relevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases. Arthritis Res Ther (2006) 0.97
Kidney pericytes: roles in regeneration and fibrosis. Semin Nephrol (2014) 0.95
Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction? Cells (2015) 0.94
Pericytes at the intersection between tissue regeneration and pathology. Clin Sci (Lond) (2015) 0.92
Origins of fibrosis: pericytes take centre stage. F1000Prime Rep (2013) 0.88
Type of MRI contrast, tissue gadolinium, and fibrosis. Am J Physiol Renal Physiol (2014) 0.84
Stem cells in airway smooth muscle: state of the art. Proc Am Thorac Soc (2008) 0.83
Ribosomal biogenesis induction by high glucose requires activation of upstream binding factor in kidney glomerular epithelial cells. Am J Physiol Renal Physiol (2010) 0.82
Acute hyperglycemia rapidly stimulates VEGF mRNA translation in the kidney. Role of angiotensin type 2 receptor (AT2). Cell Signal (2010) 0.81
Reciprocal induction of simple organogenesis by mouse kidney progenitor cells in three-dimensional co-culture. Am J Pathol (2011) 0.79
Microvascular pericytes in healthy and diseased kidneys. Int J Nephrol Renovasc Dis (2014) 0.78
Sphingosine-1-phosphate induces differentiation of cultured renal tubular epithelial cells under Rho kinase activation via the S1P2 receptor. Clin Exp Nephrol (2014) 0.76
Tubular atrophy in the pathogenesis of chronic kidney disease progression. Pediatr Nephrol (2015) 0.76
Ablation of endothelial prolyl hydroxylase domain protein-2 promotes renal vascular remodelling and fibrosis in mice. J Cell Mol Med (2017) 0.75
Aggravated renal tubular damage and interstitial fibrosis in mice lacking guanylyl cyclase-A (GC-A), a receptor for atrial and B-type natriuretic peptides. Clin Exp Nephrol (2014) 0.75
mTORC2 Signaling Regulates Nox4-Induced Podocyte Depletion in Diabetes. Antioxid Redox Signal (2016) 0.75
Ultrastructural study of electron dense deposits in renal tubular basement membrane: prevalence and relationship to epithelial atrophy. Ultrastruct Pathol (2014) 0.75
Three-dimensional biomimetic vascular model reveals a RhoA, Rac1, and N-cadherin balance in mural cell-endothelial cell-regulated barrier function. Proc Natl Acad Sci U S A (2017) 0.75
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med (1993) 18.15
Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest (2003) 12.56
Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest (2002) 12.22
Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol (2001) 7.40
Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol (1981) 4.75
Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol (1997) 3.67
Functional studies of the kidney of living animals using multicolor two-photon microscopy. Am J Physiol Cell Physiol (2002) 3.09
Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res (1991) 2.39
Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int (1998) 2.35
Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab Invest (2003) 2.27
Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases. J Am Soc Nephrol (2003) 2.16
Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling. J Am Soc Nephrol (2001) 1.98
A progressive glomerulosclerosis occurring in partial five-sixths nephrectomized rats. Am J Pathol (1975) 1.92
Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension (1998) 1.90
Renal injury from angiotensin II-mediated hypertension. Hypertension (1992) 1.88
Monoclonal antibody to Na,K-ATPase: immunocytochemical localization along nephron segments. Kidney Int (1985) 1.83
Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney Int (2000) 1.74
Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. Kidney Int (1994) 1.70
Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol (1996) 1.49
Stem cells in the kidney. Kidney Int (2002) 1.48
Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int (1992) 1.46
The activated mesangial cell: a glomerular "myofibroblast"? J Am Soc Nephrol (1992) 1.44
Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. Kidney Int (1997) 1.35
Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury. J Am Soc Nephrol (1994) 1.33
Glomerulosclerosis is transmitted by bone marrow-derived mesangial cell progenitors. J Clin Invest (2001) 1.32
Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-beta. Circ Res (1992) 1.21
Angiotensin II as a renal growth factor. J Am Soc Nephrol (1993) 1.20
Targeting TGF-beta overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade. Kidney Int (1998) 1.18
Relationship between alpha-smooth muscle actin expression and fibrotic changes in human kidney. Exp Nephrol (1997) 1.16
Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int (1994) 1.15
Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors. Am J Pathol (2001) 1.12
The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease. Kidney Int Suppl (2000) 1.10
The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis. Am J Kidney Dis (2000) 1.06
Angiotensin in progressive renal diseases: theory and practice. J Am Soc Nephrol (1996) 1.05
Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin a nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am J Kidney Dis (1994) 1.05
Transdifferentiation: a new angle on renal fibrosis. Exp Nephrol (1997) 1.04
Sequential expression of cellular fibronectin by platelets, macrophages, and mesangial cells in proliferative glomerulonephritis. Am J Pathol (1994) 1.02
Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring. Kidney Int Suppl (1997) 0.96
Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy. Kidney Int (1997) 0.93
Renal and vascular injury induced by exogenous angiotensin II is AT1 receptor-dependent. Nephron (2001) 0.91
Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis. Kidney Int (2000) 0.89
Temporal expression of autocrine growth factors corresponds to morphological features of mesangial proliferation in Habu snake venom-induced glomerulonephritis. Am J Pathol (1993) 0.88
Expression of embryonic fibronectin isoform EIIIA parallels alpha-smooth muscle actin in maturing and diseased kidney. J Histochem Cytochem (1999) 0.86
Expression of alternatively spliced fibronectin variants during remodeling in proliferative glomerulonephritis. Am J Pathol (1995) 0.86
Hepatic and renal differentiation from blood-borne stem cells. Gene Ther (2002) 0.86
Phenotypic features of cortical interstitial cells potentially important in fibrosis. Kidney Int Suppl (1996) 0.83
Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms. Kidney Int (1994) 0.83
Angiotensin II receptor antagonists in the prevention of radiation nephropathy. Radiat Res (1996) 0.83
Expression of plasminogen activator-inhibitor-1 (PAI-1) during cellular remodeling in proliferative glomerulonephritis in the rat. J Histochem Cytochem (1995) 0.82
The role of underlying nephropathy in the progression of renal disease. Kidney Int Suppl (2000) 0.81
Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem (2005) 2.98
Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Diabetes (2009) 1.87
IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation. Am J Physiol Heart Circ Physiol (2007) 1.82
NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts. J Am Soc Nephrol (2009) 1.80
AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes. J Biol Chem (2010) 1.60
Calcineurin is activated in diabetes and is required for glomerular hypertrophy and ECM accumulation. Am J Physiol Renal Physiol (2002) 1.45
Regulation of elongation phase of mRNA translation in diabetic nephropathy: amelioration by rapamycin. Am J Pathol (2007) 1.41
Kidney involvement in a nongenetic rat model of type 2 diabetes. Kidney Int (2005) 1.31
Inhibition of autoregulated TGFbeta signaling simultaneously enhances proliferation and differentiation of kidney epithelium and promotes repair following renal ischemia. Am J Pathol (2009) 1.27
Calcineurin A-alpha but not A-beta is required for normal kidney development and function. Am J Pathol (2004) 1.24
Docosahexaenoic acid-enriched fish oil attenuates kidney disease and prolongs median and maximal life span of autoimmune lupus-prone mice. J Immunol (2010) 1.22
ZO-1 expression and phosphorylation in diabetic nephropathy. Diabetes (2006) 1.14
Mammalian target of rapamycin regulates Nox4-mediated podocyte depletion in diabetic renal injury. Diabetes (2013) 1.08
Loss of calcineurin Aalpha results in altered trafficking of AQP2 and in nephrogenic diabetes insipidus. J Cell Sci (2006) 1.04
Morphological insights into the origin of glomerular endothelial and mesangial cells and their precursors. J Histochem Cytochem (2003) 0.98
Translational regulation of vascular endothelial growth factor expression in renal epithelial cells by angiotensin II. Am J Physiol Renal Physiol (2004) 0.97
Differential expression of calcineurin A isoforms in the diabetic kidney. J Am Soc Nephrol (2004) 0.97
PRAS40 acts as a nodal regulator of high glucose-induced TORC1 activation in glomerular mesangial cell hypertrophy. J Cell Physiol (2010) 0.95
ADAM17 mediates Nox4 expression and NADPH oxidase activity in the kidney cortex of OVE26 mice. Am J Physiol Renal Physiol (2013) 0.95
Resveratrol ameliorates high glucose-induced protein synthesis in glomerular epithelial cells. Cell Signal (2009) 0.94
Nephrogenic systemic fibrosis: evidence for oxidative stress and bone marrow-derived fibrocytes in skin, liver, and heart lesions using a 5/6 nephrectomy rodent model. Am J Pathol (2012) 0.86
Fibronectin induces ureteric bud cells branching and cellular cord and tubule formation. Kidney Int (2004) 0.84
Ribosomal biogenesis induction by high glucose requires activation of upstream binding factor in kidney glomerular epithelial cells. Am J Physiol Renal Physiol (2010) 0.82
Molecular events in matrix protein metabolism in the aging kidney. Aging Cell (2012) 0.82
Role of β-adrenergic receptors in regulation of hepatic fat accumulation during aging. J Endocrinol (2012) 0.81
The malnutrition-related increase in early visceralization of Leishmania donovani is associated with a reduced number of lymph node phagocytes and altered conduit system flow. PLoS Negl Trop Dis (2013) 0.81
Acute hyperglycemia rapidly stimulates VEGF mRNA translation in the kidney. Role of angiotensin type 2 receptor (AT2). Cell Signal (2010) 0.81
Concentrated fish oil (Lovaza(R)) extends lifespan and attenuates kidney disease in lupus-prone short-lived (NZBxNZW)F1 mice. Exp Biol Med (Maywood) (2013) 0.80
Reciprocal induction of simple organogenesis by mouse kidney progenitor cells in three-dimensional co-culture. Am J Pathol (2011) 0.79
Rat mesangial alpha-endosulfine. Kidney Int (2004) 0.78
Renal histopathology of a baboon model with type 2 diabetes. Toxicol Pathol (2012) 0.76